Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for In-Process Uniformity of Blend Testing – V 2.0

Posted on By

Tablets: SOP for In-Process Uniformity of Blend Testing – V 2.0

Standard Operating Procedure for In-Process Uniformity of Blend Testing

Department Tablet
SOP No. SOP/TAB/158/2025
Supersedes SOP/TAB/158/2022
Page No. Page 1 of 6
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

To define the procedure for conducting in-process testing of blend uniformity during tablet manufacturing to ensure that the mixture of ingredients is consistent and within the specified quality standards.

2. Scope

This SOP applies to the testing of blend uniformity during the tablet manufacturing process, ensuring uniform distribution of active pharmaceutical ingredients (APIs) and excipients throughout the blend.

3. Responsibilities

  • Quality Control (QC): Responsible for conducting the blend uniformity test and documenting results. QC will also recommend corrective actions if deviations are observed.
  • Production Operator: Responsible for ensuring that the blend is prepared as per the batch record and notifying QC when the blend is ready for testing.
  • Quality Assurance (QA): Ensures that the blend uniformity testing process is compliant with SOP requirements and reviews the results for consistency with product specifications.

4. Accountability

The QC Manager is accountable for ensuring that the blend uniformity testing is conducted regularly during the manufacturing process. The QA Manager ensures the

procedure is followed and results are documented appropriately.

See also  Tablets: SOP for Adhesion Testing of Coated Tablets During Production - V 2.0

5. Procedure

5.1 Preparation for Testing

  1. Verify that the blending equipment has been cleaned and calibrated according to the SOP for equipment qualification.
  2. Ensure that the batch of materials is ready for blending, including proper mixing of active ingredients and excipients.
  3. Prepare the required testing equipment, including sampling tools, scales, and containers for blend sampling.
  4. Confirm that the blend is prepared in accordance with the batch record and formulation requirements.

5.2 Sampling of the Blend

  1. Take a sample of the blend from different points within the blending equipment to ensure that the sample is representative of the entire batch.
  2. Follow the sampling plan for the number of samples to be taken and the locations from which the samples should be collected.
  3. Ensure that the samples are properly labeled with batch information and time of sampling to ensure traceability.

5.3 Blend Uniformity Testing

  1. Weigh each sample of the blend and test for uniformity using a method approved by the QC department (e.g., content uniformity or weight variation test).
  2. For content uniformity testing, check the active ingredient concentration in the sample to ensure it is within the specified range.
  3. If the testing method is weight variation, ensure that each sample meets the predetermined weight variation criteria specified in the batch record.
  4. If an automated system is used for testing, ensure the system is calibrated and functioning properly before testing the samples.
See also  Tablets: SOP for Conducting Risk Assessments for New Tablet Products - V 2.0

5.4 Documentation of Results

  1. Record the results of the blend uniformity testing in the batch record (Annexure-2), including the test method used, the results for each sample, and any deviations from the specification.
  2. For failed tests, initiate a deviation report (Annexure-1) and document the cause of the failure and any corrective actions taken.
  3. Ensure that the documentation includes relevant details such as sample locations, batch number, test conditions, and any corrective measures taken.

5.5 Corrective Actions for Blend Uniformity Issues

  1. If the blend uniformity test results do not meet the specifications, investigate the cause. Potential causes could include inadequate mixing, equipment malfunction, or incorrect formulation.
  2. Adjust the blending process as needed, including adjusting mixing time, speed, or batch size, and re-sample the blend for further testing.
  3. If the issue persists, consider reworking the batch or investigating other potential causes, such as raw material quality issues.
  4. Ensure that all corrective actions are documented and reviewed by the QA team for approval.

5.6 Acceptance Criteria

  1. The blend is considered acceptable if the test results fall within the established limits for uniformity, as defined in the batch record and specifications.
  2. If more than a specified percentage (e.g., 2%) of the samples fail to meet the uniformity specifications, initiate a full investigation and corrective actions.

5.7 Post-Testing Actions

  1. If the blend is acceptable, proceed with the next step in the tablet manufacturing process, such as tablet compression or coating.
  2. If the blend is rejected, review the blending process, investigate the root cause, and take corrective actions as necessary. Re-sample and retest the blend before proceeding with tablet manufacturing.
See also  Tablets: SOP for X-Ray Powder Diffraction for API Analysis in Tablets - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Batch Record (Annexure-2)
  2. Deviation Report (Annexure-1)

8. References

  • USP <701> – Uniformity of Dosage Units
  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • European Pharmacopoeia (EP) – Guidelines for Tablet Manufacturing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Deviation Report

Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
15/12/2025 Batch 001 Blend uniformity failed the content uniformity test Adjusted mixing time and reworked batch John Doe

Annexure-2: Batch Record

Sample Number Blend Uniformity Test Result Moisture Content Tested By
Sample 1 Pass 3.2% Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated sampling and testing procedures Improved uniformity testing accuracy QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: Capsule: SOP for Maintaining Capsule Appearance During Packaging – V 2.0
Next Post: SOP for Identification and Removal of Expired Raw Materials from Storage – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version